June 28, 2022
1 min watch
Save
VIDEO: CAR T-cells show quicker transduction time in multiple myeloma
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Amrita Krishnan, MD, director of the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope Cancer Center, discusses major developments in multiple myeloma presented at ASCO Annual Meeting.
Krishnan highlights new data on chimeric antigen receptor T cells, including indications that CAR T cells have significant room for growth in the multiple myeloma sphere.
“It suggests that we have further space to optimize our CAR-T products in terms of efficacy and time to delivery to the patient,” Krishnan said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Krishnan reports leadership roles with Sutro Biopharma; research funding to her institution from Janssen; consultant/advisory roles with Bristol Myers Squibb, GlaxoSmithKline and Janssen; speakers bureau roles with Amgen, Bristol Myers Squibb, GlaxoSmithKline and Takeda; and stock ownership in Bristol Myers Squibb.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.